The conversation around GLP-1 receptor agonists — semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound) — has gone mainstream. But the difference between a successful, sustainable weight loss outcome and a frustrating or unsafe experience almost always comes down to one thing: physician oversight.

How GLP-1 Medications Work

GLP-1 (glucagon-like peptide-1) is an incretin hormone naturally released from the gut in response to food. It stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and — critically — acts on the hypothalamus to reduce appetite and increase satiety signaling.

Semaglutide mimics and amplifies this effect. The result is a significant reduction in caloric intake that most patients describe not as willpower, but as simply not being hungry. When combined with appropriate lifestyle modifications, the clinical trial data shows 15–20% total body weight reduction over 68 weeks — outcomes that weren’t possible with any previous medical intervention short of bariatric surgery.

What Responsible Prescribing Looks Like

The telehealth weight loss mills that sprung up to capitalize on GLP-1 demand have created real problems — patients getting prescribed without cardiovascular evaluation, without thyroid history review, without monitoring for pancreatitis risk, and without any guidance on the muscle loss that accompanies rapid weight reduction without protein optimization and resistance training.

At Renew Republic, our GLP-1 protocols begin with:

• Full metabolic panel, HbA1c, lipid panel
• Thyroid screening (semaglutide is contraindicated with personal/family history of MEN2 or medullary thyroid carcinoma)
• Cardiovascular risk assessment
• Body composition analysis — we track fat mass vs. lean mass throughout treatment
• Protein and resistance training protocol — protecting muscle mass during weight loss is non-negotiable

Compounded vs. Brand-Name Medications

We prescribe both FDA-approved brand-name GLP-1 medications and, where appropriate and legally compliant, compounded semaglutide from licensed 503B compounding pharmacies. Compounded options are significantly more accessible from a cost standpoint and have allowed many patients to maintain their protocol during brand-name supply shortages. We’re transparent about the differences and help you make the choice that fits your situation.

The Combination Approach

GLP-1 therapy works best when integrated into a comprehensive metabolic optimization plan. Many of our GLP-1 patients also benefit from peptide therapy for lean mass preservation (BPC-157, CJC-1295), hormonal optimization if deficiencies are identified, and IV therapy to prevent the nutritional deficiencies that can occur with significantly reduced caloric intake.

Ready to explore whether GLP-1 therapy is appropriate for you? Book a consultation with our Houston physician team to start with the right evaluation.

GLP-1 receptor agonists are prescription medications requiring physician evaluation and ongoing monitoring. This content is educational and does not constitute medical advice.

Related Articles

• BPC-157: The Physician’s Guide to Peptide-Assisted Healing
• Frequently Asked Questions About Our Services
• Before & After Results Gallery